7 photos

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• 

  Figure 1: The typical drug development and approval process

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 2 favorites
  • 24,091 views
  • Date uploaded: 2020-02-03
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
  • Visibility: public
• 

  Figure 2: The lock and key analogy for drug-target interactions

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 16,162 views
  • Date uploaded: 2020-02-03
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
  • Visibility: public
• 

  Figure 4: Machine learning could accelerate drug development

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 13,504 views
  • Date uploaded: 2020-02-03
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
  • Visibility: public
• 

  Figure 5: Challenges hindering the use of machine learning in drug development

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 10,625 views
  • Date uploaded: 2020-02-03
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
  • Visibility: public
• Figure 1: Food and Drug Administration’s (FDA) Typical Drug Development and Approval Process

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 1 favorite
  • 6,778 views
  • Date uploaded: 2017-07-19
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao17564, investigationalnewdrugs, bla, biologicslicenseapplication, cber, centerforbiologicsevaluationandresearch, cder, centerfordrugevaluationandresearch, compac, compassionateuseadvisorycommittee, fda, foodanddrugadministration, ind, investigationalnewdrugapplication, irb, institutionalreviewboard, nda, newdrugapplication, nyu, newyorkuniversity
  • Visibility: public
• Figure 1: Percentage of New Part B Drugs Approved by the Food and Drug Administration, 2006-2013, by Condition Approved to Treat

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,508 views
  • Date uploaded: 2015-12-10
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao1612, medicarepartb, asp, averagesalesprice, awp, averagewholesaleprice, bla, biologicslicenseapplication, cms, centersformedicaremedicaidservices, dme, durablemedicalequipment, fda, foodanddrugadministration, fdca, fooddrugandcosmeticact, ffs, feeforservice, hhs, departmentofhealthandhumanservices, ind, investigationalnewdrug, nda, newdrugapplication, ndc, nationaldrugcode, nme, newmolecularentity, noc, nototherwiseclassified, wac, wholesaleacquisitioncost, vaccines
  • Visibility: public
• Figure 1: Number of Drug Shortages from 2010 through 2015

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,592 views
  • Date uploaded: 2016-08-05
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16595, drugshortages, anda, abbreviatednewdrugapplication, ashp, americansocietyofhealthsystempharmacists, dss, drugshortagestaff, fda, foodanddrugadministration, hhs, departmentofhealthandhumanservices, nda, newdrugapplication, uudis, universityofutahdruginformationservice
  • Visibility: public